| Title | Vaccine: X |
| Abbreviation | Vaccine: X |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Immunology and Microbiology (miscellaneous) (Q1); Infectious Diseases (Q1); Molecular Medicine (Q1); Public Health, Environmental and Occupational Health (Q1); Veterinary (miscellaneous) (Q1) |
| h-index | 13 |
| Overall Rank/Ranking | 2114 |
| SCImago Journal Rank (SJR) | 1.509 |
| Impact Score | 3.48 |
| Publisher | Elsevier Ltd. |
| Country | United Kingdom |
| ISSN | 25901362 |
| Best Quartile | Q1 |
| Coverage History | 2019-2022 |
Vaccine: X is a journal covering the technologies/fields/categories related to Immunology and Microbiology (miscellaneous) (Q1); Infectious Diseases (Q1); Molecular Medicine (Q1); Public Health, Environmental and Occupational Health (Q1); Veterinary (miscellaneous) (Q1). It is published by Elsevier Ltd.. The overall rank of Vaccine: X is 2114. According to SCImago Journal Rank (SJR), this journal is ranked 1.509. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 13. The best quartile for this journal is Q1.
The ISSN of Vaccine: X journal is 25901362. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Vaccine: X is cited by a total of 329 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Vaccine: X is 3.48, which is computed in 2023 as per its definition. Vaccine: X IF is decreased by a factor of 0.21 and approximate percentage change is -5.69% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Vaccine: X is 3.48. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.48 |
| 2021 | 3.69 |
| 2020 | 2.92 |
| 2019 | 0.00 |
Vaccine: X has an h-index of 13. It means 13 articles of this journal have more than 13 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Vaccine: X is 25901362. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Vaccine: X is 2114. According to SCImago Journal Rank (SJR), this journal is ranked 1.509. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.509 |
| 2021 | 1.129 |
| 2020 | 1.316 |
| 2019 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2114 |
| 2021 | 3363 |
| 2020 | 2825 |
| 2019 | 32689 |
Vaccine: X is published by Elsevier Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2019-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Vaccine: X is Vaccine: X. This abbreviation ('Vaccine: X') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Immunology and Microbiology (miscellaneous) (Q1); Infectious Diseases (Q1); Molecular Medicine (Q1); Public Health, Environmental and Occupational Health (Q1); Veterinary (miscellaneous) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Vaccine: X latest impact IF is 3.48. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.69 (2021) and 0.00 (2019), respectively, in the last 4 years. Moreover, its average IS is 2.52 in the previous 4 years.
The Vaccine: X has an SJR (SCImago Journal Rank) of 1.509, according to the latest data. It is computed in the year 2023. In the past 4 years, this journal has recorded a range of SJR, with the highest being 1.509 in 2022 and the lowest being in 2019. Furthermore, the average SJR of the Vaccine: X over the previous 4-year period stands at 2.52.
The latest h-index of the Vaccine: X is 13.
The Vaccine: X is published by the Elsevier Ltd., with its country of publication being the United Kingdom.
The Vaccine: X is currently ranked 2114 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 4 years, this journal has experienced varying rankings, reaching its highest position of 2114 in 2022 and its lowest position of 32689 in 2019.
The standard ISO4 abbreviation for the Vaccine: X is Vaccine: X.
Vaccine: X is classified as a journal that the Elsevier Ltd. publishes.
The Vaccine: X encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Vaccine: X is assigned the following International Standard Serial Numbers (ISSN): 25901362.
The best quartile for the Vaccine: X is Q1 (2022).
The Vaccine: X coverage history can be summarized as follows: 2019-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8920 | Springer Netherlands | 26 | 2.28 |
| Journal of Geriatric Physical Therapy | journal | 5578 | Lippincott Williams and Wilkins Ltd. | 43 | 1.80 |
| World Englishes | journal | 4960 | Wiley-Blackwell | 60 | 1.97 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Howard Journal of Communications | journal | 9564 | Taylor and Francis Ltd. | 36 | 1.66 |
| Libyan Studies | journal | 16122 | Cambridge University Press | 8 | 0.45 |
| Asian Textile Journal | trade journal | 27455 | G P S Kwatra | 10 | 0.01 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| Proceedings of the Royal Society of Queensland | journal | 22998 | Royal Society of Queensland | 12 | 0.48 |
| Journal of Sociology | journal | 6009 | SAGE Publications Ltd | 58 | 3.21 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.48 |
| 2021 | 3.69 |
| 2020 | 2.92 |
| 2019 | 0.00 |
